ClinicalTrials.gov
ClinicalTrials.gov Menu

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01502020
Recruitment Status : Completed
First Posted : December 30, 2011
Last Update Posted : December 30, 2011
Sponsor:
Information provided by (Responsible Party):
Actavis Mid-Atlantic LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : November 2011